Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

What really happened after Colorado legalized marijuana?

Lauren Vogel
CMAJ October 15, 2018 190 (41) E1237-E1238; DOI: https://doi.org/10.1503/cmaj.109-5665
Lauren Vogel
CMAJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Colorado often comes up in discussions about legalizing cannabis, either as a model or a cautionary tale. According to Andrew Freedman, the state’s former marijuana czar, it’s both.

For better or worse, it is unclear how much has changed in the five years since Colorado legalized cannabis, said Freedman at the recent Recovery Capital Conference in Toronto. It’s too soon to know the long-term health impacts of the policy. However, there have been concerning increases in poisonings and fatal road accidents involving cannabis. And questions remain about heavy users and highly potent products.

There are also lessons for Canada, Freedman said, because Colorado’s legal pot regime is “more in line with the commercialization that Canada is attempting” than other states. These lessons are often lost, however, in the polarized debate about legalization.

Figure

Legal pot advocates and critics alike cite data from Colorado to support their respective stances but may be missing the bigger picture.

Image courtesy of KaraGrubis/iStock

Teens do perceive marijuana as less risky now, but that doesn’t appear to have affected their use, said Freedman. When it comes to teen use in the past 30 days, for example, “you will hear a lot of different statistics about what happened.” Some cite a 20% increase from 2011/12 to the beginning of legalization in 2013/14. Others cite a 20% decrease from 2012/13 to 2015/16. But overall, “we’ve seen almost statistically flatline use,” said Freedman. “We’ve remained somewhere between 9% and 11% for the past decade.”

There have been anecdotal reports about an increase in school suspensions involving drugs, but again, “we didn’t see statistically significant changes,” Freedman said. The data on suspensions aren’t that useful, anyway, because it doesn’t differentiate which drug was involved.

Although cannabis use among adults has increased, from more than 12% of the population in 2012/13 to more than 16% in 2015/16, “we were surprised that the rate of change didn’t change,” Freedman said. Legalization didn’t change prior trends showing that “Coloradans like marijuana and they like it more over time.” The only statistically significant increase occurred among people over age 65, likely because they’re using the drug for pain relief.

The state was unprepared, however, for the risks posed by edible cannabis products to people who take too much by mistake. “They end up having an acute psychotic break and they’re calling poison control and ending up in hospital,” said Freedman. After a young tourist fatally jumped from a hotel balcony after consuming too many pieces of a cannabis cookie, the state introduced emergency regulations. These included dosing limits, warning labels, safer packaging, and bans on products that look like kids’ candy.

At the peak of the problem, there were 230 poison control calls in a year. However, “the same year we got 6500 calls for alcohol poisoning,” Freedman noted. “If you’re looking where to spend resources, know that alcohol remains a bigger problem.”

More troubling are the early trends in the percentage of drivers involved in fatal accidents who test positive for tetra-hydrocannabinol (THC), the principal psychoactive component of cannabis. That percentage has doubled since legalization, from 10% of all drivers involved in fatal crashes in 2013 to 20% in 2016. Freedman noted that the data aren’t conclusive. It doesn’t tell you if a driver was high, since THC can stay in the blood for up to a month, and it doesn’t tell you if marijuana caused the accident, he explained. Nevertheless, “I think we have a problem here.”

The marijuana industry has pushed backed on these concerns, citing studies that show people drive slower while high. “I think this is one of the places where industry behaved irresponsibly,” Freedman said. “People driving 10 kilometers under the speed limit on the highway are a danger.”

The state has also struggled in finding the right messages to educate the public about the risks of using cannabis. An initial campaign that warned “don’t be a lab rat” was panned as a return to the condescending rhetoric of the war on drugs. A later campaign that asked students to consider if cannabis would help them achieve their goals was more successful. Surveys showed youth “not only retained that message but were less likely to engage in marijuana use,” Freedman said.

Another frustration is the lack of data on daily and heavy use of cannabis. Twenty percent of marijuana users account for 80% of consumption, Freedman said. For industry, “the only way to grow the market is to get that twenty percent to use more or to start using at a younger age,” he explained. “Everything we learned in tobacco and alcohol will apply here, but groups have to galvanize early and understand that this is an ongoing battle that’s coming.”

The fact that there are no checks on the potency of cannabis products in Colorado “remains a big problem,” Freedman said. Most cannabis research uses products with much lower potency than those used recreationally. Some concentrated products can be 80% or 90% THC by volume, but are regulated the same as less potent products, Freedman explained. “It’s really something that Canada is going to have to lead the way on.”

Footnotes

  • Posted on cmajnews.com on Sept. 26, 2018.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 190 (41)
CMAJ
Vol. 190, Issue 41
15 Oct 2018
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
What really happened after Colorado legalized marijuana?
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
What really happened after Colorado legalized marijuana?
Lauren Vogel
CMAJ Oct 2018, 190 (41) E1237-E1238; DOI: 10.1503/cmaj.109-5665

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
What really happened after Colorado legalized marijuana?
Lauren Vogel
CMAJ Oct 2018, 190 (41) E1237-E1238; DOI: 10.1503/cmaj.109-5665
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Monkeypox: tracking the global health emergency
  • Making sense of monkeypox death rates
  • Providing abortions to Americans could land Canadian doctors in legal trouble — without CMPA assistance
Show more News

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire